Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

RATIONALE: One of the major complaints most people face during aging is an impairment in cognitive functioning. This has a negative impact on the quality of daily life and is even more prominent in patients suffering from neurodegenerative and psychiatric disorders including Alzheimer’s disease, sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Reneerkens, Olga A. H., Rutten, Kris, Steinbusch, Harry W. M., Blokland, Arjan, Prickaerts, Jos
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704616/
https://www.ncbi.nlm.nih.gov/pubmed/18709359
http://dx.doi.org/10.1007/s00213-008-1273-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704616/
https://www.ncbi.nlm.nih.gov/pubmed/18709359
http://dx.doi.org/10.1007/s00213-008-1273-x

Ejemplares similares